Behind the video

Hims & Hers DOWN 7%: Is This a Disaster? | $HIMS

The thesis, the calls, and the words behind them. Play a quote to hear it in the original video.

Asymmetric Investing by Travis HoiumAug 11, 2026Watch on YouTube

Overall SentimentBullishStrength: 75%

Overall Thesis

Hims & Hers reported strong long-term growth fundamentals with 50%+ expected growth in H2 2026, but near-term margin pressure from customer acquisition investments is causing short-term stock weakness.

Narratives

HIMSHims & Hers Health

Strongly Bullish

Travis views Hims & Hers as the biggest holding in his portfolio, believing the company is deliberately sacrificing short-term margins to acquire subscribers and build a long-term healthcare aggregator platform. He argues the recent stock drop is a short-term overreaction to margin compression, while the underlying growth trajectory (accelerating revenue, subscriber adds, expanding treatment categories) is strengthening.

Key Arguments

Subscribers grew over 300,000 sequentially to 2.89 million, partly boosted by the Eucalyptus acquisition
Monthly revenue per subscriber jumped from $8 to $92 due to GLP1 weight loss products via Novo Nordisk and Eli Lilly deals
Full-year revenue guidance raised to $3.1-3.3 billion from $2.8-3.0 billion, with 50%+ growth expected in the second half of 2026
International expansion (Eucalyptus, Zava, Canada) is driving growth beyond the US market
Customer acquisition economics improve over time as cumulative gross profit per customer builds each quarter, similar to software company lifetime-value models
Long-term aggregator thesis: adding specialties like peptides and hormone health will keep expanding subscriber base toward 5-20 million

Risks acknowledged

Gross margin fell from ~80% to 63.8% due to lower-margin branded GLP1 products
Adjusted EBITDA margin guidance was cut from ~11% to 9%, and the high end of EBITDA guidance was reduced from $350 million to $325 million
Legal reserves tied to an FTC issue are weighing on near-term margins
Stock fell about 7% after hours and remained down roughly 2.8% pre-market on the margin disappointment

Predictions (2)

Bullnext few days and weeks

Not scoredDetails

"I wouldn't be surprised to see that turnaround over the next few days and weeks."

Bullby 2029, maybe 2028

Not scoredDetails

Hedges & Caveats

Short-term market reaction negative despite long-term bullish thesis
Margin compression expected due to customer acquisition cost investments
Growth-versus-profitability trade-off creates investor uncertainty
Presenter acknowledges tension between growth and near-term profitability
Stock down 7% after earnings despite positive long-term outlook

Analyzed with claude-sonnet-5 | Extraction v1.0.0 | Cost: $0.07